Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2003
09/23/2003US6624184 Amide and diamide inhibitors of IMPDH enzyme for use in treating IMPDH-associated disorders
09/23/2003US6624178 Novel compounds of the pyridinium series useful for the management of diabetes and aging-related vascular complications, including kidney disease, nerve damage, atherosclerosis, retinopathy, dermatological disorders and
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624164 1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them
09/23/2003US6624163 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and Attention Deficit Hyperactivity Disorder
09/23/2003US6624157 Antitumor agents
09/23/2003US6624152 Inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention relates to pharmaceutical formulations comprising these compounds and methods of using them for inflammatory and autoimmune diseases
09/23/2003US6623739 Oil-in-water emulsions containing metabolizable oil and alpha tocopherol; enhancing immune responses to given antigen
09/23/2003CA2268927C Aqueous-based pharmaceutical composition
09/23/2003CA2068027C Pharmaceutical compositions comprising an anticytokine
09/19/2003WO2002072077A2 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/19/2003CA2457192A1 Use of amino acids, amino acid analogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
09/18/2003WO2003076602A2 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076455A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076438A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076437A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
09/18/2003WO2003076436A1 Derivatives of 4- (imidazol-5-yl)-2-(4-sulfoanilino) pyrimidine with cdk inhibitory activity
09/18/2003WO2003076435A1 Pyrimidine compounds
09/18/2003WO2003076434A1 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
09/18/2003WO2003076433A1 Pyrimidine compounds
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076430A1 Amino-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076421A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003076402A1 Therapeutic agent for pain
09/18/2003WO2003076400A1 New inhibitors of histone deacetylase
09/18/2003WO2003076399A1 Compounds capable of inhibiting immunocyte-related allergic immune reactions
09/18/2003WO2003075953A2 Immunomodulatory polymeric antigens for treating inflammatory pathogies
09/18/2003WO2003075952A1 Methods of enhancing immune induction involving mda-7
09/18/2003WO2003075940A1 An extract of lentinus lepideus and composition comprising the same showing immune enhancing activity
09/18/2003WO2003075939A1 Soybean saponin-containing material and process for producing the same
09/18/2003WO2003075935A1 Drugs containing riboflavin-type compounds
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003WO2003075929A1 Inhibitors of histone deacetylase
09/18/2003WO2003075891A1 Dispersed solid-containing complex carbohydrate
09/18/2003WO2003075857A2 Amino-methyl substituted tetracycline compounds
09/18/2003WO2003075741A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN αvβ3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
09/18/2003WO2003075685A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
09/18/2003WO2003075676A1 Probiotic delivery system
09/18/2003WO2003075670A1 Treatment and prevention of inflammatory disorders
09/18/2003WO2003053915A3 Compounds for the treatment of inflammatory disorders
09/18/2003WO2003053368A3 Chalcone derivatives and their use to treat diseases
09/18/2003WO2003051893A3 Improvements in pharmaceutical compositions
09/18/2003WO2003051807A3 Improvements in pharmaceutical compositions
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003039595A3 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
09/18/2003WO2003037308A3 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
09/18/2003WO2003035007A3 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
09/18/2003WO2003032928A3 Therapeutic composition and use
09/18/2003WO2003024419A3 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002085410A3 Method for evaluating the efficacy of treatment with bacterial dna and bacterial cell walls
09/18/2003WO2002083700B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
09/18/2003WO2002080982A3 Nucleic acid mucosal immunization
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002062750A9 Cannabinoid receptor ligands
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002036110A9 Oral self-emulsifying formulations of pyranone protease inhibitors
09/18/2003WO2002032455A3 Vaccine
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176642 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors
09/18/2003US20030176498 Inhibitors of alpha4mediated cell adhesion
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176496 Administering an antiproliferative agent in combination with a potentiating effective amount of a N- substituted dithiocarbamate ester or a pharmaceutically acceptable salt thereof
09/18/2003US20030176487 For therapy and prophylaxis of disorders related to unregulated tyrosine kinase signal transduction, including cell proliferative and metabolic disorders
09/18/2003US20030176482 Imidazole derivatives or their salts
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176460 Piperidine compounds for use as ccr-3 inhibitors
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176441 Inhibitsthe binding of eotaxin to the CCR-3 receptor and thereby provide a means of combating eosinophil induced diseases, such as asthma
09/18/2003US20030176433 For therapy and prophylaxis of hepatitis C virus (HCV) infection
09/18/2003US20030176430 For therapy and prophylaxis of Tachykinin-mediated diseases
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/18/2003US20030176413 Polycyclic guanine derivative phosphodiesterase V inhibitors
09/18/2003US20030176409 Administering a low dose of estrogen to mammal
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176400 For therapy of allergic diseases such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis
09/18/2003US20030176383 Antisense modulation of p38 mitogen activated protein kinase expression
09/18/2003US20030176378 Vaccines and gene therapy compositions and methods of making and using the same
09/18/2003US20030176363 For therapy of T lymphocyte mediated inflammatory diseases in animals and man
09/18/2003US20030176341 For use as an anti-viral, anti-tumour or immunomodulatory agent
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176315 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175934 Controlling cell differentiation, cell proliferation; anticancer agents
09/18/2003US20030175920 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
09/18/2003US20030175901 Genetic engineering; polyketides
09/18/2003US20030175898 Isolated nucleic acids; immune response disease
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175840 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175731 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
1 ... 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 ... 1172